UK Launches AI Biosecurity Lab Backed by Up to £300 Million From OpenAI and Anthropic
The UK government has launched the AI Biosecurity Lab (AIBL), a new body that will use frontier AI models to detect biological threats earlier and speed up vaccine and treatment development. The Cabinet Office announced the lab on October 24, 2026, backed by up to £300 million in combined funding from the government and technology companies including OpenAI and Anthropic.
The lab sits under a wider National AI Biosecurity Initiative and will work on two priorities first: catching emerging biological threats earlier, and accelerating the development of vaccines, treatments and other medical countermeasures, according to the Cabinet Office’s own announcement.

How the funding breaks down
Of the up to £300 million total, the UK government is putting in £100 million directly. The remaining up to £200 million comes from company commitments rather than cash grants to the lab itself.
OpenAI is committing £100 million in compute and model credits, along with trusted access to its most capable relevant models through its Rosalind Biodefense programme. Anthropic is committing up to £100 million in model credits, along with trusted model access and dedicated technical support, per the Cabinet Office.
| Funder | Commitment | Form |
|---|---|---|
| UK government | £100 million | Direct funding |
| OpenAI | Up to £100 million | Compute and model credits, plus Rosalind Biodefense programme access |
| Anthropic | Up to £100 million | Model credits and technical support |
Who else is involved
Google DeepMind is named as a partner, contributing biosecurity expertise and access to its Gemini models, though the Cabinet Office’s announcement does not attach a monetary figure to DeepMind’s role. Basecamp Research, a UK-based AI life sciences company, is also a partner, providing AI-biology models and biosecurity expertise.
On the government side, the lab will work with the UK Health Security Agency, the Animal and Plant Health Agency, the Defence Science and Technology Laboratory, and the Medicines and Healthcare products Regulatory Agency, according to the Cabinet Office.
What the Rosalind Biodefense programme already does
OpenAI’s Rosalind Biodefense programme is not new. OpenAI launched it on May 29, 2026, to give vetted outside developers access to GPT-Rosalind, a gated life-sciences model, for building pandemic-preparedness and biosecurity tools, R&D World reported, citing OpenAI’s own announcement. R&D World described GPT-Rosalind as a frontier reasoning model built specifically for life-sciences and pandemic-preparedness work, distinct from OpenAI’s general-purpose models.
Early access partners named at that May launch included Lawrence Livermore National Laboratory, which is pairing the model with its supercomputing work to design and evaluate medical countermeasures, Johns Hopkins Applied Physics Laboratory, which is integrating the model into a protein-engineering platform, and the Coalition for Epidemic Preparedness Innovations, which is applying it to its 100 Days Mission for faster vaccine development. OpenAI said at the time that “frontier AI should meaningfully advantage those defenders,” referring to biodefense researchers over bad actors.
Why this matters
The lab is one of the largest public-private AI commitments to biosecurity announced by any government to date, and it is notable for lining up two rival frontier AI labs, OpenAI and Anthropic, as named technical partners on the same government initiative rather than competing separately for the contract.
It also builds on an existing UK relationship with both companies. The government’s AI Safety Institute was renamed the AI Security Institute on February 14, 2025, a change that shifted its remit toward security risks such as how AI could be misused to develop chemical and biological weapons, TechCrunch reported. The same day, the institute signed a voluntary memorandum of understanding with Anthropic covering security research and responsible deployment of its models. The new lab extends that biological-risk focus into a dedicated, separately funded body rather than folding it into the security institute’s existing remit.
What happens next
The Cabinet Office’s announcement does not set out a public operating timeline, named lab leadership, or a physical location for AIBL. Praman News will follow up once the lab confirms its leadership and its first areas of active work.
FAQ
What is the AI Biosecurity Lab?
A new UK government body, launched October 24, 2026 under the National AI Biosecurity Initiative, that will use frontier AI models to detect biological threats earlier and speed up vaccine and treatment development.
How much funding is involved, and who is paying?
Up to £300 million total: £100 million directly from the UK government, plus up to £100 million each in model credits and technical support from OpenAI and Anthropic.
Is this the same as the UK AI Security Institute?
No. The AI Security Institute, renamed from the AI Safety Institute in February 2025, already covers AI-related chemical and biological weapon risks as part of a broader security remit. AIBL is a separate, dedicated body under the newer National AI Biosecurity Initiative.

Leave a Reply